Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s10637-007-9085-0
| Title: | A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells | Authors: | Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. |
Keywords: | 3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine |
Issue Date: | 2008 | Citation: | Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S. (2008). A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Investigational New Drugs 26 (2) : 169-173. ScholarBank@NUS Repository. https://doi.org/10.1007/s10637-007-9085-0 | Source Title: | Investigational New Drugs | URI: | http://scholarbank.nus.edu.sg/handle/10635/27208 | ISSN: | 01676997 | DOI: | 10.1007/s10637-007-9085-0 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.